Research map: Dual efficacy of tocilizumab in managing PD-1 inhibitors-induced myocardial inflammatory injury and suppressing tumor growth with PD-1 inhibitors: a preclinical study

Back to the article

Papers in this map

  1. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma · Jedd D. Wolchok · 2017 · 5454 citations · Cited by this paper
  2. Immunocytokines and cytokine neutralization for cancer immunotherapy · Pedro Berraondo · 2025 · 14 citations · Cites this paper
  3. HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression · 2026 · Related
  4. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma · James Larkin · 2019 · 3789 citations · Cited by this paper
  5. Acetylation of FABP3 alleviates radioimmunotherapy-induced cardiomyocyte senescence by modulating long-chain polyunsaturated fatty acid metabolism · Yuxi Luo · 2025 · 7 citations · Cites this paper
  6. Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma · 2026 · Related
  7. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial · Yelena Yuriy Janjigian · 2021 · 3119 citations · Cited by this paper
  8. The role of the PD-1/PD-L1 immune checkpoint pathway in myocardial infarction: a review from pathophysiological mechanisms to therapeutic strategies · Zilong Luo · 2025 · 4 citations · Cites this paper
  9. Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma · 2026 · Related
  10. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up · John B.A.G. Haanen · 2017 · 2383 citations · Cited by this paper
  11. Immune checkpoint inhibitor-induced myocarditis: focus on the downstream pathogenic components and potential therapeutics · Yifan Chen · 2025 · 4 citations · Cites this paper
  12. Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma · 2026 · Related
  13. Fulminant Myocarditis with Combination Immune Checkpoint Blockade · Douglas Buckner Johnson · 2016 · 2337 citations · Cited by this paper
  14. Decoding the Cardiac Immune Microenvironment and Fibroblast Crosstalk in Radiotherapy Combined with Immunotherapy‐Induced Cardiac Fibrosis Based on Single‐Cell Transcriptomic Analysis · Yuxi Luo · 2026 · 3 citations · Cites this paper
  15. Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma · 2026 · Related
  16. Revisiting STAT3 signalling in cancer: new and unexpected biological functions · Hua Yu · 2014 · 2187 citations · Cited by this paper
  17. Immune checkpoint inhibitor-related pneumonitis: current advances and the putative role of mesenchymal stem cell therapy · Zekang Li · 2026 · 2 citations · Cites this paper
  18. Integrative single-cell and multi-omics analysis of ZBTB21-mediated serine metabolism in colorectal cancer: from metabolic reprogramming to immune microenvironment modulation · 2026 · Related
  19. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper · Stéphane Champiat · 2015 · 913 citations · Cited by this paper
  20. Kaempferol attenuates LPS-induced inflammatory responses in H9c2 cells through involvement of the IL-6/JAK2/STAT3 pathway · Hongyi Yue · 2026 · 2 citations · Cites this paper
  21. Squeezing Treatment-Induced Metabolic Alterations in Melanoma Cells Are Accompanied by Impaired Cluster of Differentiation 8-Positive T Cell and Natural Killer Cell Antitumor Effector Functions · 2026 · Related
  22. Cardiovascular toxicities associated with immune checkpoint inhibitors · Jiun‐Ruey Hu · 2019 · 520 citations · Cited by this paper
  23. Unveiling the global research status and intellectual map of cancer and immunosuppressants · Tianyi Yuan · 2025 · 1 citation · Cites this paper
  24. Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade · Chipman Stroud · 2017 · 332 citations · Cited by this paper
  25. KCTD10 weakens m6A modification of IL‐11 in a ubiquitin‐dependent manner to repress tumour immune escape in lung adenocarcinoma · Yufen Xu · 2026 · 1 citation · Cites this paper
  26. Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment · Hirotake Tsukamoto · 2018 · 309 citations · Cited by this paper
  27. Immune checkpoint inhibitor-induced cardiotoxicity: from immune mechanisms to clinical surveillance and targeted therapies · Nathan K. Chen · 2026 · Cites this paper
  28. Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis · Pan Ma · 2023 · 178 citations · Cited by this paper
  29. Pathological mechanisms and treatment strategies for immune checkpoint inhibitor-associated myocarditis: insights from single-cell sequencing · Yameng Zhao · 2026 · Cites this paper
  30. Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting Cytokines · Jee Hye Kang · 2021 · 116 citations · Cited by this paper
  31. Heterogeneity of macrophages in PD-1/PD-L1 inhibitor therapy: a single-cell perspective · Jinjing Wu · 2026 · Cites this paper
  32. Overview of the anti-inflammatory function of the innate immune sensor NLRC3 · Yue Zhao · 2022 · 20 citations · Cited by this paper
  33. The Cardio-Onco-Immune Axis: immunopathological mechanisms in the cardiac microenvironment of checkpoint inhibitor-induced myocarditis · Lian-ke Liang · 2026 · Cites this paper
  34. Untitled · Cited by this paper
  35. Immune checkpoint inhibitor‐induced arrhythmias: Mechanistic insights from clinical and preclinical studies · Anand R. Ramalingam · 2026 · Cites this paper
  36. Untitled · Cited by this paper
  37. Untitled · Cited by this paper
  38. Untitled · Cited by this paper
  39. Untitled · Cited by this paper

Source: OpenAlex (CC0)